Cognitive Reappraisal Training for Borderline Personality
BPD
2 other identifiers
interventional
60
1 country
1
Brief Summary
Previous work by the study group convinced the study team to pursue development of focused cognitive reappraisal training as a novel approach to treatment of BPD, either as stand-alone treatment or in concert with evidence-based treatments of BPD. The present proposal aims to refine and test a proposed clinical intervention for BPD patients, training in reappraisal-by-distancing, in terms of its ability to influence hypothesized neural and behavioral targets and, once that is established, to demonstrate its ability improve clinically relevant outcome measures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2021
CompletedFirst Posted
Study publicly available on registry
July 19, 2021
CompletedStudy Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 3, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 3, 2024
CompletedResults Posted
Study results publicly available
August 5, 2025
CompletedAugust 5, 2025
July 1, 2025
2.5 years
July 8, 2021
June 4, 2025
July 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in PINES Network Activity
BOLD signal change in Picture Induced Negative Emotion Signature (PINES) network activity that includes the amygdala, insula, and other regions by measuring neural activation using fMRI.
Baseline and up to 6 weeks of treatment
Change in Zanarini Rating Scale for Borderline Personality (ZAN-BPD)
Zanarini Rating Scale for Borderline Personality, self-report. Full scale from 0-36. Higher score indicates poorer health outcomes.
Baseline and up to 6 weeks of treatment
Secondary Outcomes (6)
Change in ZAN-BPD Sector Scores
Baseline and at 2-,4-, and 6-weeks
Change in Affective Lability Scale Total (ALS)
Baseline and at 2-,4-, and 6-weeks
Change in Perceived Stress Scale (PSS)
Baseline and at 2-,4-, and 6-weeks
Change in Difficulty in Emotion Regulation Scale Scores (DERS)
Baseline and at 2-,4-, and 6-weeks
Change in Beck Depression Scale Score (BDI)
Baseline and at 2-,4-, and 6-weeks
- +1 more secondary outcomes
Study Arms (2)
Cognitive Reappraisal-by-Distancing (CRD)
EXPERIMENTALSubjects will be coached to use cognitive reappraisal-by-distancing to downregulate their negative reactions to aversive emotional pictures usng practice pictures.
Control Downregulate Condition (CD)
ACTIVE COMPARATORSubjects will be coached to practice their customary emotion regulatory techniques in a treatment occurring twice a week for 6 weeks.
Interventions
Reappraisal-by-distancing treatment. Participants meet 2 times a week for 6 weeks to learn reappraisal by distancing through repeated practice with negative emotional pictures. The therapist will help model and shape the technique. .
Participants either meet 2x a week for 6- weeks to gain added practice, under the guidance of a therapist, using their customary emotion regulatory strategies to downregulate their negative reactions to aversive pictures.
Eligibility Criteria
You may qualify if:
- Medically healthy men and women with Borderline Personality Disorder who are mentally competent and give informed voluntary written consent.
- Subjects who are being treated with psychotherapy or psychopharmacotherapy will be included so long as there has been no change in that treatment over the preceding 2 months.
You may not qualify if:
- Age \> 55
- Criteria for Schizotypal Personality Disorder or Avoidant Personality Disorder. SPD is excluded to avoid possible confound from the restricted affect that characterizes SPD and co-morbid AvPD subjects will be excluded because the researchers have shown that their patterns of neural activity in emotion processing are distinct from BPD subjects.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Icahn School of Medicine at Mount Sinailead
- William Marsh Rice Universitycollaborator
- National Institute of Mental Health (NIMH)collaborator
Study Sites (1)
Icahn School of Medicine at Mount Sinai
New York, New York, 10024, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Harold W Koenigsberg
- Organization
- Icahn School of Medicine at Mount Sinai
Study Officials
- PRINCIPAL INVESTIGATOR
Harold Koenigsberg, MD
Icahn School of Medicine at Mount Sinai
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Psychiatry
Study Record Dates
First Submitted
July 8, 2021
First Posted
July 19, 2021
Study Start
December 1, 2021
Primary Completion
June 3, 2024
Study Completion
June 3, 2024
Last Updated
August 5, 2025
Results First Posted
August 5, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Beginning 9 months and ending 36 months following article publication.
- Access Criteria
- Investigators whose proposed use of the data has been approved by an independent review committee identified for this purpose. For individual participant data meta-analysis.
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).